WCG Clinical

JULY 12, 2023

Princeton, NJ, July 12, 2023 – WCG, one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, released its 2023 Avoca State of the Industry Report. Avoca joined the WCG family of companies in April 2021. For more information, visit www.theavocagroup.com.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

BioTech 365

OCTOBER 29, 2020

HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) today announced it has entered into a strategic alliance with the NYU Grossman School of Medicine’s Department of Radiation Oncology that provides a framework for preclinical and clinical development projects studying Tumor Treating Fields.

Medicine 40

Medicine Clinical Research Clinical Development Research 40

ACRP blog

DECEMBER 28, 2022

From AI and machine learning producing an era of rapid new pathways, to an industry-wide push for equitable representation in clinical trials, 2023 will be a catalytic year for biopharma clinical development and commercialization,” the company notes in its press release on this, its 13th annual trends report.

Clinical Research 59

Clinical Research Research Clinical Trials Clinical Trials 59

Clinical Trial Podcast

SEPTEMBER 26, 2022

Cohen has more than 30 years of healthcare experience which includes his work on clinical development. such as Senior Vice President, Global Head of Early Clinical Development and Precision Medicine, Senior Vice President, Clinical Research Strategies, Vice President and Senior Director, Medical and Scientific Services, among others.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

XTalks

DECEMBER 13, 2023

This episode features an interview with vaccine scientists and executives from Vaccines Global Clinical Development at Merck, Dr. Heather Platt, MD, Distinguished Scientist and Pneumococcal Vaccine Lead; and Dr. Ulrike Buchwald, MD, Scientific Associate Vice President, Global Clinical Research and Pneumococcal Vaccine Section Head.

Life Science 52

Life Science Vaccination Vaccine Scientist 52

Outsourcing Pharma

AUGUST 3, 2021

The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.

Research 130

Research Scientist Clinical Research Medicine 130

Pharmaceutical Technology

OCTOBER 11, 2022

It is claimed to be the only grade of sulforaphane which is suitable for clinical research and will eventually be approved as a medicine. Evgen CEO Dr Huw Jones said: “This is an exciting opportunity to work with Stalicla to develop a potential treatment for ASD and other neuropsychiatric disorders.

Clinical Development 147

Clinical Development Licensing Licensing Clinical Research 147

XTalks

AUGUST 22, 2023

Yet, 41 percent of people in the US have no knowledge of the clinical research process, and 91 percent say they’ve never been given the opportunity to participate in a trial, according to SCORR Marketing. The availability of new medicines is reliant upon individuals’ willingness to contribute to clinical trials. “The

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

Pharmaceutical Technology

MARCH 30, 2023

In a 29 March press release, the FDA stated that Lupus ABC will bring voices together in a centralised forum to define challenges in drug development and analyse potential approaches to help advance therapies. Lupus is a difficult to treat – it has a range of symptoms and is poorly understood.

Development 162

Development Drugs FDA Approval Clinical Development 162

The Pharma Data

SEPTEMBER 29, 2021

Heerspink, Professor of Clinical Trials and Personalized Medicine and a clinical pharmacologist/trialist at the Department of Clinical Pharmacy and Pharmacology at the University center Groningen, Netherlands, and Co-Chair of the study’s Executive Committee.

Clinical Development 52

Clinical Development Development Clinical Trials Clinical Trials 52

Pharmaceutical Technology

FEBRUARY 24, 2023

(Lopinavir + ritonavir) is under clinical development by Douglas Pharmaceuticals and currently in Phase I for Genital Warts (Condylomata Acuminata). Douglas Pharmaceuticals overview Douglas Pharmaceuticals (Douglas) carries out the development and manufacture of nutraceutical and health products.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

Pharmaceutical Technology

FEBRUARY 24, 2023

(Lopinavir + ritonavir) is under clinical development by Douglas Pharmaceuticals and currently in Phase I for Cervical Intraepithelial Neoplasia (CIN). Douglas Pharmaceuticals overview Douglas Pharmaceuticals (Douglas) carries out the development and manufacture of nutraceutical and health products.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

Drug Discovery World

MARCH 15, 2024

We are excited to begin the next phase of development with the initiation of two 28-day patient studies, the first studies of ALX-001 in people living with Alzheimer’s and Parkinson’s disease,” commented Tim Siegert, Chief Operating Officer and Co-Founder of Allyx Therapeutics. “We

Trials 52

Trials Drugs Clinical Development Development 52

ACRP blog

MAY 9, 2024

Their willingness to involve themselves in a new process, and to trust clinical researchers and product developers with their time and wellbeing, is a significant contribution. There are barriers that often derive from trial complexity, deeply rooted historical mistrust, or a lack of awareness about clinical research.

Clinical Trials 69

Clinical Trials Clinical Trials Clinical Research Trials 69

Worldwide Clinical Trials

MARCH 7, 2024

One key decision is whether to file an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) or a Clinical Trial Application (CTA) with the European Medicines Agency (EMA) and respective regulatory agencies of its member states.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Worldwide Clinical Trials

MAY 1, 2024

For clinical research professionals, this journey often involves reconciling differing feedback from regulatory agencies, each with unique standards, priorities, and expectations. An illustrative example of harmonization between agencies exists via the European Medicines Agency (EMA) and U.S.

Clinical Research 173

Clinical Research Trials Research Clinical Trials 173

XTalks

JANUARY 17, 2024

There are many aspects of oncology drug development that are driven by the unique nature of the treatments being developed and the needs of the patients, their caregivers and the doctors that treat them. Dr. Vidal is a certified medical oncologist with extensive experience in oncology drug development.

Clinical Trials 124

Clinical Trials Clinical Trials Trials Gene Therapy 124

Drug Discovery World

APRIL 25, 2023

“We have reached an important milestone with the dosing of the second participant in our clinical trial evaluating a potentially groundbreaking CAR-T cell therapy to cure HIV,” said Mehrdad Abedi, Professor of Internal Medicine, Hematology and Oncology and co-investigator of the study. “So

Research 52

Research In-Vitro Clinical Trials Clinical Trials 52

Drug Discovery World

MARCH 28, 2023

iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer, has been awarded the innovative medicine designation, the Innovation Passport, for roginolisib, for the treatment of metastatic uveal melanoma by the Medicines & Healthcare products Regulatory Agency (MHRA).

Drugs 52

Drugs Clinical Development Medicine Development 52

XTalks

MAY 9, 2024

As we explore Genmab’s strategic vision, technological advancements and the next frontier in antibody research, we gain insights into the future of medicine — a future where Genmab’s cutting-edge therapies are poised to transform patient care and meet the complex challenges of the next generation of healthcare.

Antibody 52

Antibody Clinical Trials Clinical Trials Medicine 52

Drug Discovery World

MAY 17, 2023

Leveraging historical trial databases has become commonplace in assessing the feasibility of trials in therapeutic areas with a large breadth of clinical development history. EHR data also has a key role to play in designing future clinical trials.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Genetics 52

pharmaphorum

JUNE 27, 2022

The analysis – from a dataset that spans more than half a million patients – reveals once again the lack of inclusivity in clinical research, which undermines the ability of clinical trials to generate results that reflect the real-world situation in US cancer treatment.

Trials 112

Trials Clinical Trials Clinical Trials Clinical Research 112

pharmaphorum

DECEMBER 1, 2022

A recent survey of clinical trial professionals found that more than two-thirds of respondents (61%) believe giving patients choice will have a positive impact on clinical research, and well over half (58%) said that their organisations plan to give patients the option to choose how they participate in clinical trials moving forward.

Clinical Trials 111

Clinical Trials Clinical Trials Trials Clinical Research 111

XTalks

MAY 23, 2024

With over 25 years of experience, Dr. Duke’s expertise in growth and bone disorders has been instrumental in advancing clinical research and improving patient outcomes. Advancements in genomic technology, precision medicine and gene therapy offer hope for personalized treatments and improved outcomes.

Clinical Trials 52

Clinical Trials Clinical Trials Hormones Trials 52

VirTrial

FEBRUARY 28, 2024

Webinar Takeaways In light of recent draft guidance from the FDA on core patient-reported outcomes (PROs) in cancer trials and on dose optimization in oncology drug development – thoughtful collection and interpretation of patient experience data in oncology clinical research is becoming even more critical.

Development 52

Development Drugs Trials Clinical Development 52

pharmaphorum

DECEMBER 2, 2022

Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and precision medicine targeting more niche patient populations. The integration of trial planning and execution data will be a key win for clinical development. Integration of data is key.

Trials 98

Trials Clinical Trials Clinical Trials Clinical Research 98

Drug Discovery World

FEBRUARY 10, 2023

The research will support the clinical development of CTx001, CTx’s lead gene therapy asset for the treatment of GA, by enabling the identification of patients with complement-driven AMD for future interventional studies.

Gene Therapy 52

Gene Therapy Gene Genetics Clinical Development 52

The Pharma Data

SEPTEMBER 28, 2021

Triple-negative carcinoma grows and spreads faster than other sorts of carcinoma and consequently features a worse prognosis,” said Dr. Vicki Goodman, vice chairman , clinical research, Merck Research Laboratories. Merck has the industry’s largest immuno-oncology clinical research program. About Merck.

Hormones 52

Hormones Medicine Clinical Research Research 52

XTalks

MAY 19, 2023

It is clear that the clinical research landscape continues to expand at a substantial rate. Growing Complexity of Clinical Trials Research teams are increasingly dealing with complex clinical trial designs and clinical research complexity. percent, 81.1 percent, 84.9 percent and 87.2

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

Worldwide Clinical Trials

MAY 20, 2022

Though some of the disparity can be attributed to the difficulty of advanced therapeutic development, it is more a testament to the influx of research in the past few years that is only beginning to flow through development. Since 2020, the FDA has released 12 guidances or draft guidances related to cell and gene therapies 2.

Gene Therapy 130

Gene Therapy Gene Development Research 130

Pharmaceutical Technology

JULY 18, 2022

There are currently no approved therapies for the treatment of bronchiectasis; although some off-label medicines do exist, they only alleviate symptoms and manage frequent infections. There have recently, however, been some notable developments towards improving the care of bronchiectasis patients.

Marketing 147

Marketing Trials Development Protein 147

Advarra

AUGUST 14, 2023

The clinical research industry is only becoming more complex and competitive as organizations are inundated with multiple trials and tight deadlines. The clinical trial process is both expensive and time-consuming, and ends more often in failure than success. of respondents reported they know what clinical trials are.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

XTalks

MARCH 5, 2021

With locations in 40 countries worldwide, ICON offers a full range of consulting, clinical development and commercialization services. ICON previously acquired MAPI in 2017, having made it the second-largest provider of late-stage clinical development services after IQVIA at the time.

Development 98

Development Trials Clinical Development Medicine 98

Advarra

NOVEMBER 29, 2022

The field of cell and gene therapies (CGT) is constantly evolving, and there has been significant progress in this area of research. However, despite the promise of these therapies, the regulations governing them lag the science, which in turn hinders the clinical translation of these novel medicines.

Gene Therapy 52

Gene Therapy Gene Production Clinical Trials 52

The Pharma Data

JANUARY 4, 2021

From 2016 to 2018, he served as chief development officer for oncology at Pfizer, where he was responsible for leading clinical research, development, and lifecycle management of all promising oncology products. Habtezion has spent the past 10 years at Stanford University.

HR 52

HR Clinical Development Scientist Pharma Companies 52

XTalks

SEPTEMBER 21, 2023

“HIV continues to be a major global public health challenge with no approved vaccines despite decades of research efforts,” said Carey Hwang, Vir’s Senior Vice President, Clinical Research, Head of Chronic Infection, in the company’s press release.

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. Oral therapy data presented at ASH. Professional reception of the findings.

Development 52

Development Drugs Clinical Development Antibody 52